Previous close | 78.42 |
Open | 79.58 |
Bid | 39.72 x 800 |
Ask | 79.48 x 900 |
Day's range | 79.36 - 80.08 |
52-week range | 69.44 - 88.23 |
Volume | |
Avg. volume | 901,808 |
Market cap | 39.247B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 40.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.27 (0.34%) |
Ex-dividend date | 10 May 2024 |
1y target est | N/A |
GENEVA, April 07, 2024--Alcon Publishes Agenda for 2024 Annual General Meeting
BENGALURU, India, March 12, 2024--The release will introduce Alcon's latest Intraocular Lens technology in India
TORONTO, March 06, 2024--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’